[Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

Rhea-AI Filing Summary

Roland Rott, listed as an officer (CEO, Imaging) of GE HealthCare Technologies Inc. (GEHC), reported transactions on 09/01/2025 involving common stock tied to the vesting of restricted stock units. The Form 4 shows three disposition entries coded F (withholding to satisfy tax obligations) for 685, 690 and 459 shares, each executed at $73.73 per share. The reported amounts of common stock beneficially owned following each reported transaction are 29,550, 28,860 and 28,401 shares respectively. The form is signed on behalf of the reporting person by Frank R. Jimenez as attorney-in-fact.

Insights

Financial Analyst

TL;DR: Routine tax-withholding dispositions tied to RSU vesting; transactions are small relative to company float and present no material signal.

The Form 4 discloses share withholding to satisfy tax obligations on vested restricted stock units, executed at $73.73 per share. The transactions are coded as withholding (F) and reduce the reporting person’s beneficial holdings by modest amounts (hundreds of shares per line). There is no indication of open-market sales or compensatory cash transactions beyond tax-related withholding. For investors, this type of filing typically reflects routine compensation mechanics rather than a change in company outlook or insider sentiment.

Corporate Governance Expert

TL;DR: Disclosure appears complete for RSU tax-withholding; signature by attorney-in-fact follows common practice and shows compliance.

The report shows the reporting person’s relationship to the issuer as an officer (CEO, Imaging) and discloses three withholding events to satisfy tax liabilities upon RSU vesting. The presence of an attorney-in-fact signature is a standard mechanism for timely filing. There are no indications of unusual beneficiary arrangements or indirect ownership claims in the provided sections. Overall, the filing evidences compliance with SEC Section 16 reporting obligations for insider compensation-related share movements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rott Roland

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Imaging

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	09/01/2025		F		685(1)	D	$73.73	29,550	D
Common Stock, par value $0.01 per share	09/01/2025		F		690(1)	D	$73.73	28,860	D
Common Stock, par value $0.01 per share	09/01/2025		F		459(1)	D	$73.73	28,401	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did GEHC insider Roland Rott report on Form 4?

The Form 4 reports three dispositions on 09/01/2025 coded F (withholding for taxes) for 685, 690, and 459 shares at $73.73 per share.

Why were shares disposed of according to the GEHC Form 4 for Roland Rott?

The filing states the dispositions were due to withholding of shares to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

What is Roland Rott's role at GE HealthCare Technologies (GEHC) in the Form 4?

The Form 4 lists Roland Rott as an officer with the title CEO, Imaging and also marks him as a director.

At what price were the shares withheld on the GEHC Form 4?

Each reported disposition on the form lists a price of $73.73 per share.

Who signed the Form 4 for Roland Rott and in what capacity?

The Form 4 is signed by Frank R. Jimenez, General Counsel and Corporate Secretary, acting as attorney-in-fact on behalf of the reporting person.

How many shares did Roland Rott beneficially own after the reported transactions?

The form reports beneficial ownership amounts following each transaction as 29,550, 28,860, and 28,401 shares respectively.